Company Name, Ticker, Competitors, else..
HOME
INDUSTRIES
NEWS
MARKETS
ECONOMY
SCREENING
GLOSSARY
HELP
Company Profile
Syros Pharmaceuticals Inc News
Syros Pharmaceuticals Inc's Inventory Turnover Ratio
Syros Pharmaceuticals Inc's Dividend Growth
Syros Pharmaceuticals Inc Business Description
Syros Pharmaceuticals Inc Executive Officers
Economic Indicators
Fundamentals
Syros Pharmaceuticals Inc Growth Rates
Syros Pharmaceuticals Inc Profitability
Syros Pharmaceuticals Inc Valuation
Syros Pharmaceuticals Inc Management Effectiveness
Syros Pharmaceuticals Inc Financial Strength
Syros Pharmaceuticals Inc Efficiency
Syros Pharmaceuticals Inc Dividend
Financials
Syros Pharmaceuticals Inc Business Segments
Syros Pharmaceuticals Inc Income Statement
Syros Pharmaceuticals Inc Balance Sheets
Syros Pharmaceuticals Inc Cash Flow Statement
Competition
Syros Pharmaceuticals Inc Market Share
Syros Pharmaceuticals Inc Competition Performance
Syros Pharmaceuticals Inc Competitors Results
SYRS Competitors Stock Performance
SYRS Competitors Growth Rates
SYRS Workforce Efficiency at the Competitors
SYRS Competitors Efficiency
SYRS Competitors Management Effectiveness
SYRS Competitors Valuation
Charts & Quotes
SYRS's Technical Analysis
Syros Pharmaceuticals Inc Comparison Charts
SYRS OHLC Charts
SYRS Line Charts
SYRS's Weekly Charts
SYRS's Monthly Charts
Home
Syros Pharmaceuticals Inc's Profile
Company Charts and Quotes
SYRS's OHLC Chart
Syros Pharmaceuticals Inc News
Syros Pharmaceuticals Inc latest News
Syros Pharmaceuticals Inc's Executive Officers
Syros Pharmaceuticals Inc's Income Statement
Syros Pharmaceuticals Inc's Balance Sheets
Syros Pharmaceuticals Inc's Cash Flow Statement
Syros Pharmaceuticals Inc's Profitability
Syros Pharmaceuticals Inc's Financials
Syros Pharmaceuticals Inc's P/FCF Ratio TTM
Syros Pharmaceuticals Inc's Competitors
Syros Pharmaceuticals Inc's Market Share
SYRS's Competitors Valuation
SYRS's Charts Technical Indicators
Economic Indicators
Financial Strength by Industry
News
Economy News
Stocks on the Move
News on Clinical Trials
Previous News
Return On Investment Screening
Year to date best performing stocks in the Healthcare
Markets at a Glance
Stocks
Cryptocurrencies
Sectors & Industries
Best performing Stocks in Major Pharmaceutical Preparations industry during the Current Month
Commodities
Foreign Exchange
Stocks in 2024
U.S. International Trade
News
Economy News
Business News
Syros Pharmaceuticals Inc latest News
Financial Terms
Syros Pharmaceuticals Inc
(NASDAQ:
SYRS
)
Other Ticker:
Sector
•
Healthcare
Industry
•
Major Pharmaceutical Preparations
Industry
•
Major Pharmaceutical Preparations
Sector
•
Healthcare
SYRS's comparison of Quarterly Growth Rates to its Peers
(in %)
Select the Relationship:
Peers ▼
Competition
Customers
Suppliers
Major Pharmaceutical Preparations
Healthcare
Select the Category:
Comparison ▼
Quarterly Results
Stock Performance
Growth Rates
Per Employee
Efficiency
Management Effectiveness
Valuation
Market Share
Peers ▼
Customers
Suppliers
Major Pharmaceutical Preparations
Healthcare
Growth Rates▼
Basic Data
Quarterly Results
Stock Performance
Growth Rates
Per Employee
Efficiency
Management Effectiveness
Data by Segment
Market Share
COMPANY NAME
TICKER
REV. Y / Y
REV. SEQ.
INC. Y / Y
INC. SEQ.
Syros Pharmaceuticals Inc
3 Q
SYRS
-
-
-
-
Vertex Pharmaceuticals Inc
1 Q
VRTX
2.96 %
-4.87 %
-41.22 %
-29.21 %
Jazz Pharmaceuticals Plc
1 Q
JAZZ
-0.46 %
-17.49 %
-
-
Biomarin Pharmaceutical Inc
1 Q
BMRN
14.84 %
-0.29 %
109.43 %
48.62 %
Alnylam Pharmaceuticals Inc
1 Q
ALNY
20.2 %
0.17 %
-
-
Protagonist Therapeutics inc
1 Q
PTGX
-88.89 %
-83.4 %
-
-
Supernus Pharmaceuticals inc
1 Q
SUPN
4.3 %
-13.97 %
-
-
Blueprint Medicines Corporation
1 Q
BPMC
55.45 %
2.08 %
-99.44 %
-
Zai Lab Limited
1 Q
ZLAB
22.19 %
-2.37 %
-
-
Intercept Pharmaceuticals inc
3 Q
ICPT
14.44 %
6.06 %
-
-
Tg Therapeutics Inc
1 Q
TGTX
90.4 %
11.71 %
-
-78.31 %
Affimed N v
4 Q
AFMD
-79.99 %
-79.99 %
-
-
G1 Therapeutics Inc
2 Q
GTHX
-60.97 %
14.3 %
-
-
Deciphera Pharmaceuticals Inc
1 Q
DCPH
34.55 %
-6.82 %
-
-
Rhythm Pharmaceuticals inc
1 Q
RYTM
25.94 %
-21.82 %
-
-
Y mabs Therapeutics inc
1 Q
YMAB
4.88 %
-21.1 %
-
-
Adagene Inc
4 Q
ADAG
-99.43 %
-99.43 %
-
-
Adc Therapeutics Sa
1 Q
ADCT
27.59 %
36.21 %
-
-
Alimera Sciences Inc
2 Q
ALIM
52.92 %
15.5 %
-
-
Nurix Therapeutics Inc
1 Q
NRIX
11.26 %
38.91 %
-
-
Xencor Inc
1 Q
XNCR
104.61 %
-38 %
-
-
Puretech Health Plc
4 Q
PRTC
-78.68 %
-78.68 %
-
-
Wave Life Sciences Ltd
1 Q
WVE
-26.82 %
-89.04 %
-
-
Zymeworks Inc
1 Q
ZYME
170.29 %
-12.64 %
-
-
Mersana Therapeutics inc
1 Q
MRSN
-70.21 %
-83.17 %
-
-
Agios Pharmaceuticals Inc
4 Q
AGIO
51.06 %
19.7 %
-
-
Mirati Therapeutics Inc
3 Q
MRTX
201.97 %
19.8 %
-
-
Whitehawk Therapeutics Inc
1 Q
WHWK
33.48 %
-
-
-
Bolt Biotherapeutics Inc
1 Q
BOLT
-76.83 %
1.3758496861617E+17 %
-
-
Aravive Inc
3 Q
ARAV
-44.39 %
116.33 %
-
17.87 %
I mab
4 Q
IMAB
-
-
-
-
Tonix Pharmaceuticals Holding Corp
1 Q
TNXP
-2.14 %
-5.93 %
-
-
Phathom Pharmaceuticals Inc
1 Q
PHAT
1391.58 %
-3.86 %
-
-
Xoma Royalty Corporation
1 Q
XOMA
967.92 %
82.6 %
-
-
Janux Therapeutics Inc
1 Q
JANX
-
-
-
-
Shattuck Labs Inc
1 Q
STTK
-
-
-
-
Precigen Inc
1 Q
PGEN
25.92 %
-
-
-
Reata Pharmaceuticals Inc
2 Q
RETA
2885.04 %
11564.62 %
-
-
Werewolf Therapeutics Inc
1 Q
HOWL
-
-
-
-
Chinook Therapeutics Inc
2 Q
KDNY
141.15 %
-44.86 %
-
-
Oncternal Therapeutics Inc
3 Q
ONCT
175.98 %
-38.33 %
-
-
Lipella Pharmaceuticals Inc
1 Q
LIPO
-11.3 %
-25.49 %
-
-
Rafael Holdings Inc
1 Q
RFL
432.35 %
182.81 %
-
-
Palvella Therapeutics Inc
1 Q
PVLA
-
-
-
-
Regenerx Biopharmaceuticals inc
1 Q
RGRX
-0.01 %
0.01 %
-
-
Abvc Biopharma Inc
1 Q
ABVC
-
-
-
-
Lumos Pharma Inc
3 Q
LUMO
10271.43 %
48.77 %
-
-
Cns Pharmaceuticals Inc
1 Q
CNSP
-
-
-
-
Vaccinex Inc
4 Q
VCNX
-
-
-
-
Salarius Pharmaceuticals inc
1 Q
SLRX
-
-
-
-
Panbela Therapeutics Inc
3 Q
PBLA
-
-
-
-
Paxmedica Inc
2 Q
PXMD
-
-
-
-
Neubase Therapeutics inc
3 Q
NBSE
-
-
-
-
Phio Pharmaceuticals Corp
1 Q
PHIO
-
-
-
-
Nextcure Inc
1 Q
NXTC
-
-
-
-
Ibio inc
1 Q
IBIO
-
-
-
-
Kineta Inc
1 Q
KANT
-
-
-
-
Tempest Therapeutics Inc
1 Q
TPST
-
-
-
-
Enliven Therapeutics Inc
1 Q
ELVN
-
-
-
-
Pliant Therapeutics Inc
1 Q
PLRX
-
-
-
-
Nuvalent Inc
1 Q
NUVL
-
-
-
-
Spyre Therapeutics Inc
1 Q
SYRE
-
-
-
-
Adlai Nortye Ltd
4 Q
ANL
-
-
-
-
Verona Pharma Plc
1 Q
VRNA
-
108.04 %
-
-
Tuhura Biosciences Inc
1 Q
HURA
-
-
-
-
Rein Therapeutics Inc
1 Q
RNTX
-
-
-
-
Glycomimetics Inc
1 Q
GLYC
-
-
-
-
Lantern Pharma Inc
4 Q
LTRN
-
-
-
-
Milestone Pharmaceuticals Inc
1 Q
MIST
-
-
-
-
Day One Biopharmaceuticals Inc
1 Q
DAWN
-
5.32 %
-
-
Cytodyn inc
1 Q
CYDY
-
-
-
-
Madrigal Pharmaceuticals Inc
1 Q
MDGL
-
32.84 %
-
-
89bio Inc
1 Q
ETNB
-
-
-
-
Allakos Inc
1 Q
ALLK
-
-
-
-
Iveric Bio Inc
1 Q
ISEE
-
-
-
-
Kinnate Biopharma Inc
3 Q
KNTE
-
-
-
-
Terns Pharmaceuticals Inc
1 Q
TERN
-
-
-
-
Actinium Pharmaceuticals Inc
1 Q
ATNM
-
-
-
-
Oramed Pharmaceuticals Inc
1 Q
ORMP
-
-
-
-
Mira Pharmaceuticals Inc
4 Q
MIRA
-
-
-
-
Innovation Pharmaceuticals Inc
3 Q
CTIX
-
-
-
-
Inhibitor Therapeutics Inc
4 Q
HPPI
-
-
-
-
Tyme Technologies Inc.
2 Q
TYME
-
-
-
-
Nucana Plc
4 Q
NCNA
-
-
-
-
Effector Therapeutics Inc
1 Q
EFTR
-
-
-
-
Cadrenal Therapeutics Inc
1 Q
CVKD
-
-
-
-
APROX. MARKET
3 Q
SUBTOTAL
8.17 %
-7.91 %
-
-
More Data on Competitors
List of Competitors by Company
• Performance
• Growth Rates
• Company Data
• Efficiency
• Mgmt. Effect.
• Valuation
List of Competitors by Segment
• Market Share